BRCA1 rs1799950: Understanding This Genetic Variant
The rs1799950 variant is a specific change located within the BRCA1 gene, which is widely recognized for its role in DNA repair and tumor suppression. Research has investigated this variant for its potential association with a minor but cumulatively significant increase in breast cancer risk across various populations.
What each genotype means
Normal breast cancer risk
This genotype is considered the baseline or reference state for this variant. Research indicates that individuals with this profile do not show the slight increase in breast cancer risk associated with the G allele.
This is a common genotype, though exact frequencies vary significantly by ancestral background.
Slightly increased risk profile
Carrying one copy of the G allele has been associated with a very slight increase in breast cancer risk in some studies. Because findings regarding this variant are inconsistent across different research populations, this result should be interpreted with caution.
This genotype is observed in a portion of the population, consistent with the reported minor allele frequency of approximately 0.028.
Slightly increased risk profile
Carrying two copies of the G allele has been associated with a very slight increase in breast cancer risk in some studies. Scientific literature on this variant is mixed, and some meta-analyses have even suggested potential protective effects in specific populations, highlighting the need for clinical context.
This genotype is less common than the heterozygous state, reflecting the lower frequency of the G allele in most populations.
What is rs1799950?
The identifier rs1799950 refers to a single nucleotide polymorphism (SNP) located within the BRCA1 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is situated in exon 11 of the BRCA1 gene. Because it is a common variation, it is found in a significant portion of the population rather than being a rare mutation. Scientists study these variants to understand how subtle differences in our genetic code might influence susceptibility to complex diseases. While many SNPs have no observable effect on health, researchers focus on rs1799950 because of its location in a gene critical for maintaining genomic stability.
The Role of the BRCA1 Gene
The BRCA1 gene provides instructions for making a protein that acts as a tumor suppressor. This protein is essential for repairing damaged DNA, which helps ensure the stability of a cell's genetic material. When DNA damage occurs, the BRCA1 protein helps coordinate the repair process, preventing cells from growing and dividing too rapidly or in an uncontrolled way. Mutations that disrupt the function of BRCA1 are well-known for significantly increasing the risk of developing breast and ovarian cancers. Because of this vital function, any variation within the BRCA1 gene, such as rs1799950, is of high interest to researchers investigating how genetic differences might modulate cancer risk or influence the efficiency of DNA repair mechanisms in different individuals.
Research and Evidence Strength
The association between rs1799950 and breast cancer risk has been the subject of numerous studies, with some research suggesting a link to increased susceptibility. However, the evidence remains moderate and sometimes controversial, as results can vary significantly between different ethnic groups and study populations. For instance, some studies have reported a statistically significant association in specific cohorts, such as the Pashtun population, while other meta-analyses highlight that findings can be inconsistent across broader, more diverse groups. It is important to note that this variant is not considered a high-penetrance mutation like the rare, pathogenic BRCA1 mutations that cause hereditary breast and ovarian cancer syndrome. Instead, it is viewed as a potential susceptibility factor that may contribute to risk in a minor, cumulative way rather than acting as a primary cause of disease.
Interpreting Your Genetic Information
If you encounter information about the rs1799950 variant, it is essential to understand that genetic risk factors are only one piece of a much larger puzzle. Breast cancer is a complex condition influenced by a combination of genetic, environmental, and lifestyle factors. Having a specific genotype for this SNP does not mean an individual will develop cancer, nor does it guarantee protection. This information should never be used to make medical decisions or to self-diagnose. If you are concerned about your personal or family history of cancer, the most appropriate step is to consult with a certified genetic counselor or a healthcare professional. They can provide context based on your full medical history and help you understand the relevance of genetic testing in your specific situation.
How common is this variant?
The minor allele frequency (GMAF) for rs1799950 is approximately 0.028, though this frequency can vary significantly depending on the ancestral background of the population being studied.
Frequently asked questions
Is rs1799950 the same as a BRCA1 mutation?
No, rs1799950 is a common genetic variant, or polymorphism, rather than a rare, high-risk pathogenic mutation. While pathogenic BRCA1 mutations are strongly linked to hereditary cancer syndromes, this variant is associated with only a minor, cumulative change in risk.
Should I be worried if I have the G allele?
Genetic variants like rs1799950 are common and do not act as a direct cause of cancer. You should not be worried based on this result alone, as cancer risk is determined by many factors including family history and lifestyle.
Can I use this information to change my cancer screening?
No, you should not change your medical screening or health habits based on a single SNP result. Always discuss your genetic findings with a doctor or genetic counselor who can interpret them in the context of your overall health.
Where can I find more information about BRCA1 variants?
You can find reliable information through resources like MedlinePlus Genetics, the NCBI ClinVar database, and the GWAS Catalog. These platforms provide evidence-based summaries of how specific genetic variants relate to human health.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1799950?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BRCA1
This pathogenic variant in the BRCA1 tumor suppressor gene is associated with a significantly increased lifetime risk of hereditary breast and ovarian cancer syndrome.
This variant is classified as likely pathogenic for BRCA1-related cancer predisposition based on multifactorial likelihood analysis and functional assay data.
This variant is a pathogenic mutation associated with hereditary breast and ovarian cancer syndrome, with clinical significance supported by multiple submitters and expert curation.
This variant is a pathogenic splice-donor mutation in the BRCA1 gene associated with hereditary breast and ovarian cancer syndrome.
This variant (p.Arg1699Trp) is a well-documented pathogenic variant in the BRCA1 gene associated with increased risk of hereditary breast and ovarian cancer.
This rare variant has been recently annotated in clinical databases as a potential contributor to hereditary breast and ovarian cancer risk.